Transfusion Practices for Children in Germany, Austria, and Switzerland - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Pediatric Transfusion Practices in Germany, Austria, and Switzerland

  • By

  • Eva Wittenmeier

  • Katharina Roehrs

  • Eva Herrmann

  • Johanna H. Steinberg

  • Christiane E. Beck

  • Andrea U. Steinbicker

  • TRAPA investigator study group

  • Hannah-Sophie Arbeiter

  • Gregor Badelt

  • Karin Becke-Jakob

  • Nicole Bewersdorf

  • Carolin Böhne

  • Patrick Booms

  • Jens Brands

  • Thorsten Brenner

  • Luisa Cremers

  • Nora Doberschütz

  • Christoph Eich

  • Dania Fischer

  • Thomas Fischer

  • Peter J Follmann

  • Ulrich Gosch

  • Ulrike Herberg

  • Egbert Hüttemann

  • Martin Keller

  • Isabel Kiesewetter

  • Dieter Klarmann

  • Maren Kleine-Brueggeney

  • Svea Kleiner

  • Markus Knuf

  • Oliver Kunitz

  • Karsten Laabs

  • Matthias Lange

  • Thomas Lehrnbecher

  • Anna Katharina Masseli

  • Chris Mohrmann

  • Marcus Nemeth

  • Kornelius Padberg

  • Tobias Piegeler

  • Florian Piekarski

  • Greta A. Polley

  • Vanessa Rigterink

  • Ulrich Rochwalsky

  • Udo Rolle

  • Armin Sablewski

  • Ehrenfried Schindler

  • Miriam Schneider

  • Antje Seidel

  • Benjamin Siebald

  • Barbara Sinner

  • Ezgi Sönmez

  • Alexander Sterlin

  • Andrea Uebler

  • Reiner M. Waeschle

  • Carola Wempe

  • Astrid Wintering

  • Kai Zacharowski

  • Bernhard Ziegler

  • November 20, 2026

Share

Clinical Scorecard: Pediatric Transfusion Practices in Germany, Austria, and Switzerland

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Pediatric Transfusion Practices in Germany, Austria, and Switzerland
Key MechanismsThe study recorded transfusions of RBC, FFP, platelets, fibrinogen, PCC, and other coagulation factors, and classified clinical stability, bleeding, and impaired coagulation.
Target PopulationChildren aged 0 days to 17 years, including preterm infants and neonates, who received transfusions at participating centers in Germany, Austria, and Switzerland.
Care SettingCare setting described in the source article.

Key Highlights

  • The analysis included 1,330 transfusion events involving 1,834 blood products in children aged 0 days to 17 years.
  • Nonoperative care accounted for 56.5% of transfusion events; postoperative and intraoperative care accounted for 23.9% and 16.9%, respectively.
  • Single-product transfusions made up more than three-quarters of events; isolated RBC and platelet transfusions accounted for 45.7% and 22.6% of events.
  • Half of transfused children were classified as clinically unstable; bleeding was documented in 14.4% and impaired coagulation in 22.2% of events.
  • RBC was the predominant product in most age groups, while platelets were most frequently transfused among patients aged 12 to 17 years.

Guideline-Based Recommendations

Diagnosis

  • The study used criteria from two guidelines to classify children as clinically stable or unstable and recorded bleeding and impaired coagulation.

Management

  • The article states that pediatric guidelines recommend restrictive approaches, based predominantly on evidence from adults.
  • The study describes contemporary transfusion practice and does not provide product-specific treatment recommendations.

Monitoring & Follow-up

  • The study recorded transfusion product, clinical setting, age, clinical stability, bleeding, impaired coagulation, cardiac surgery or ECMO therapy, and oncologic treatment.

Risks

  • The article states that blood-product administration entails risks, particularly for children.
  • The study used anonymous reporting; the supplied source notes that this prevented comparisons between centers and longitudinal tracking of individual patients.

Patient & Prescribing Data

The 1,330 transfusion events comprised 855 RBC, 268 FFP, 449 platelet, 120 fibrinogen, 68 PCC, and 74 other coagulation-factor events, administered alone or in combination. RBC was predominant in most age groups; platelets were most frequent among patients aged 12 to 17 years.

Clinical Best Practices

  • Interpret the reported practice patterns in light of the article's statement that pediatric guidelines recommend restrictive approaches based predominantly on adult evidence.
  • Describe stability, bleeding, impaired coagulation, care setting, and product type as variables recorded in the study, not as treatment recommendations.
  • The anonymous study design prevented comparisons between centers and longitudinal tracking of individual patients.

Related Resources & Content

Original Source(s)

Related Content